Changchun BCHT Biotechnology Co. (688276.SS)

CNY 26.21

(-0.53%)

Total Debt Summary of Changchun BCHT Biotechnology Co.

  • Changchun BCHT Biotechnology Co.'s latest annual total debt in 2023 was 20.47 Million CNY , down 0.0% from previous year.
  • Changchun BCHT Biotechnology Co.'s latest quarterly total debt in 2024 Q3 was 62.58 Million CNY , down -41.21% from previous quarter.
  • Changchun BCHT Biotechnology Co. reported annual total debt of - CNY in 2022, down 0.0% from previous year.
  • Changchun BCHT Biotechnology Co. reported annual total debt of - CNY in 2021, down 0.0% from previous year.
  • Changchun BCHT Biotechnology Co. reported quarterly total debt of 65.4 Million CNY for 2024 Q1, up 219.48% from previous quarter.
  • Changchun BCHT Biotechnology Co. reported quarterly total debt of 106.44 Million CNY for 2024 Q2, up 62.75% from previous quarter.

Annual Total Debt Chart of Changchun BCHT Biotechnology Co. (2023 - 2017)

Historical Annual Total Debt of Changchun BCHT Biotechnology Co. (2023 - 2017)

Year Total Debt Total Debt Growth
2023 20.47 Million CNY 0.0%
2022 - CNY 0.0%
2021 - CNY 0.0%
2020 - CNY -100.0%
2019 165 Million CNY 0.0%
2018 165 Million CNY 0.0%
2017 - CNY 0.0%

Peer Total Debt Comparison of Changchun BCHT Biotechnology Co.

Name Total Debt Total Debt Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 1.58 Billion CNY 98.707%
Yabao Pharmaceutical Group Co., Ltd 209 Million CNY 90.205%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 15.79 Billion CNY 99.87%
Harbin Pharmaceutical Group Co., Ltd. 3.55 Billion CNY 99.425%
Tasly Pharmaceutical Group Co., Ltd 2.95 Billion CNY 99.308%
Zhejiang Medicine Co., Ltd. 801.44 Million CNY 97.446%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 839.84 Million CNY 97.562%
Lionco Pharmaceutical Group Co.,Ltd. 565.61 Million CNY 96.381%
Humanwell Healthcare (Group) Co.,Ltd. 9.94 Billion CNY 99.794%
Ginwa Enterprise (Group) Inc. 10.77 Million CNY -89.977%
Joincare Pharmaceutical Group Industry Co.,Ltd. 7.4 Billion CNY 99.723%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 175.68 Million CNY 88.347%
China Animal Husbandry Industry Co., Ltd. 1.45 Billion CNY 98.594%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 9.91 Million CNY -106.578%
Zhejiang Huahai Pharmaceutical Co., Ltd. 7.45 Billion CNY 99.725%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.08 Billion CNY 98.109%
Ningbo Menovo Pharmaceutical Co., Ltd. 1.3 Billion CNY 98.428%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 727.9 Million CNY 97.188%
Chongqing Taiji Industry(Group) Co.,Ltd 4.86 Billion CNY 99.579%
HPGC Renmintongtai Pharmaceutical Corporation 2.33 Billion CNY 99.123%
Nanjing Well Pharmaceutical Group Co.,Ltd. 486.95 Million CNY 95.796%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 995.24 Million CNY 97.943%
Henan Lingrui Pharmaceutical Co., Ltd. 149.26 Million CNY 86.285%
Shenzhen Chipscreen Biosciences Co., Ltd. 1.2 Billion CNY 98.299%
Guizhou Yibai Pharmaceutical Co., Ltd. 1.07 Billion CNY 98.103%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 48.13 Million CNY 57.47%
Zhongzhu Healthcare Holding Co.,Ltd 23.94 Million CNY 14.493%
Beijing Tongrentang Co., Ltd 3.42 Billion CNY 99.403%
KPC Pharmaceuticals, Inc. 1.17 Billion CNY 98.252%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 17.28 Million CNY -18.46%
North China Pharmaceutical Company Ltd. 11.72 Billion CNY 99.825%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 462.87 Million CNY 95.577%
Tibet Weixinkang Medicine Co., Ltd. 7.68 Million CNY -166.489%
China National Medicines Corporation Ltd. 3.15 Billion CNY 99.352%
Zhejiang Hisun Pharmaceutical Co., Ltd. 5.69 Billion CNY 99.64%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 3.15 Billion CNY 99.35%
ChengDu ShengNuo Biotec Co.,Ltd. 267.22 Million CNY 92.339%
Dali Pharmaceuticalco.,Ltd 23.66 Million CNY 13.483%
Zhejiang Shengda Bio-Pharm Co., Ltd. 238.44 Million CNY 91.414%
Shanghai Jiaoda Onlly Co.,Ltd 208.92 Million CNY 90.201%
Jiang Zhong Pharmaceutical Co.,Ltd 56.62 Million CNY 63.846%
Mayinglong Pharmaceutical Group Co., LTD. 380.42 Million CNY 94.619%
Cisen Pharmaceutical Co., Ltd. 170.67 Million CNY 88.005%
Hunan Warrant Pharmaceutical Co.,Ltd 24.18 Million CNY 15.34%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 35.72 Billion CNY 99.943%
Jianmin Pharmaceutical Group Co.,Ltd. 501.17 Million CNY 95.915%
Hunan Fangsheng Pharmaceutical Co., Ltd. 679.7 Million CNY 96.988%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 1.78 Billion CNY 98.853%
Guobang Pharma Ltd. 963.26 Million CNY 97.875%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 659.05 Million CNY 96.894%
Kangmei Pharmaceutical Co., Ltd. 255.01 Million CNY 91.972%
Shandong Buchang Pharmaceuticals Co., Ltd. 3.4 Billion CNY 99.399%
Zhejiang Starry Pharmaceutical Co.,Ltd. 3.19 Billion CNY 99.359%
Henan Taloph Pharmaceutical Stock Co.,Ltd 819.3 Million CNY 97.501%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 116.7 Million CNY 82.458%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 2.62 Billion CNY 99.22%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 446.65 Million CNY 95.417%
Shanghai Shyndec Pharmaceutical Co., Ltd. 1.75 Billion CNY 98.83%
Shanghai Yizhong Pharmaceutical Co., Ltd. 44.02 Million CNY 53.502%
Tibet Rhodiola Pharmaceutical Holding Co. 501.52 Million CNY 95.918%
Sichuan Huiyu Pharmaceutical Co., Ltd. 435.5 Million CNY 95.299%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 443.84 Million CNY 95.388%
CanSino Biologics Inc. 2.71 Billion CNY 99.246%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 705.78 Million CNY 97.099%
Shandong Lukang Pharmaceutical Co.,Ltd. 3.43 Billion CNY 99.404%